Send mail to Author
Sorafenib sensitizes glioma cells to the BH3 mimetic ABT-737 by targeting MCL1 in a STAT3-dependent manner (Article)Please indicate your contact information and select, which author you want to contact.
Please indicate your contact information and select, which author you want to contact.